Overview
Mylene Pezet practices practicing medicine in Grenoble, France.
Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Melanoma, and Cerebral Cavernous Malformation.
She is actively involved in clinical research, co-authoring 31 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mylene Pezet
Is Mylene Pezet a top-rated expert for Myelodysplastic Syndrome (MDS)?
MediFind is an objective health platform that identifies experts based on real-world data. Mylene Pezet is classified as an Experienced expert for Myelodysplastic Syndrome (MDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mylene Pezet participate in research or clinical trials?
Yes. Mylene Pezet has published 31 articles and abstracts on conditions like Myelodysplastic Syndrome (MDS). You can view a list of Mylene Pezet's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral Cavernous MalformationMs. Pezet isExperienced. Learn about Cerebral Cavernous Malformation.
- MelanomaMs. Pezet isExperienced. Learn about Melanoma.
- Myelodysplastic Syndrome (MDS)Ms. Pezet isExperienced. Learn about Myelodysplastic Syndrome (MDS).